[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344337-105":59,"doc-detail-344337-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","harnessing-nucleotide-metabolism-and-immunity-in-cancer-a-tumour-microenvironment-perspective-state-of-the-art-review","Harnessing nucleotide metabolism and immunity in cancer: a tumour microenvironment perspective - state-of-the-art review","","Tumour microenvironment research highlights a dynamic interface where cancer metabolism and immune function intersect, with nucleotide metabolism (NM) acting as a key driver. This review explains how NM supports DNA and RNA synthesis, why cancer cells upregulate purine and pyrimidine pathways, and how this metabolic rewiring reshapes immune viability. Altered nucleotide levels in the tumour microenvironment can suppress immune responses and promote immune evasion. It also surveys NM-targeted therapeutic approaches, including synthesis inhibitors and agents disrupting salvage pathways, emphasizing combination with immunotherapies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/harnessing-nucleotide-metabolism-and-immunity-in-cancer-a-tumour-microenvironment-perspective-state-of-the-art-review/344337/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/harnessing-nucleotide-metabolism-and-immunity-in-cancer-a-tumour-microenvironment-perspective-state-of-the-art-review/344337.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is nucleotide metabolism important for cancer cell growth?","Question",{"text":112,"@type":113},"Nucleotide metabolism is required for DNA and RNA synthesis. Cancer cells upregulate nucleotide pathways to meet the demands of rapid proliferation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does altered nucleotide metabolism affect the tumour microenvironment and immune cells?",{"text":117,"@type":113},"NM rewiring shapes the tumour microenvironment and can suppress immune response by altering the nucleotide milieu. This impacts immune cell function and viability, supporting immune evasion.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic strategies targeting nucleotide metabolism are discussed?",{"text":121,"@type":113},"The review covers strategies such as inhibitors of nucleotide synthesis and drugs targeting salvage pathways. It also emphasizes combining NM-targeted therapies with immunotherapies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344337,1790154858,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","STATE-OF-THE-ART REVIEW  \nHarnessing nucleotide metabolism and immunity in cancer: a tumour microenvironment perspective  \nHadil Suleiman 1, Alexandra Emerson 1, Peter M. Wilson2, Karl A. Mulligan2, Robert D. Ladner 1,2 and Melissa J. LaBonte 1   \n1 Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, UK  \n2 CV6 Therapeutics (NI) Ltd, Belfast, UK  \nKeywords  \ncancer immunology; immune checkpoint inhibitors; immunometabolism; metabolic therapies; nucleotide metabolism; purine metabolism; pyrimidine synthesis; therapeutic modulation; tumour microenvironment  \nCorrespondence  \nM. J. LaBonte, Medicine, Dentistry and Biomedical Sciences, Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast BT9 7AE, UK Tel: +442 890 972 789  \n[E-mail:](E-mail: m.labontewilson@qub.ac.uk)[ m.labontewilson@qub.ac.uk](E-mail: m.labontewilson@qub.ac.uk)  \nThe tumour microenvironment (TME) is a dynamic nexus where cancer cell metabolism and the immune system intricately converge, with nucleotide metabolism (NM) playing a pivotal role. This review explores the critical function of NM in cancer cell proliferation and its profound inﬂuenceon the TME and immune landscape. NM is essential for DNA and RNA synthesis and is markedly upregulated in cancer cells to meet the demands of rapid growth. This metabolic rewiring fuels cancer progression, but also shapes the TME, impacting the function and viability of immune cells. The altered nucleotide milieu in the TME can suppress immune response, aiding cancer cell evasion from immune surveillance. Drug discoveries in the ﬁeld of NM have revealed different therapeutic strategies, including inhibitors of nucleotide synthesis and drugs targeting salvage pathways, which are discussed thoroughly in this review. Furthermore, the emerging strategy  \nAbbreviations  \n5-FU, 5-ﬂuorouracil; 5-PRA, 5-phosphoribosylamine; A2A, adenosine A2A receptor; ADP, adenosine diphosphate; ADSS, adenylsuccinate synthetase; ALL, acute lymphoblastic leukaemia; AMP, adenosine monophosphate; APCs, antigen-presenting cells; Ara-C, cytarabine; Asp, aspartate; ATCase, aspartate transcarabmylase; ATP, triphosphate; CAD, phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase; CD, cluster of differentiation; cGAS, cyclic GMP-AMP synthase; CMP, cytosine monophosphate; CMPK, cytidine monophosphate kinase; CRC, colorectal cancer; CTL, cytotoxic T-lymphocyte; CTP, cytidine triphosphate; CTPS, CTP synthase; d,‘deoxy’; DC, dendritic cell; DHFR, dihydrofolate reductase; DHO, dihydroorotase; DHODH, dihydroorotate dehydrogenase; DNA, deoxyribonucleic acid; dNTP, deoxynucleoside triphosphate; DPD, dihydropyrimidine dehydrogenase; dUTPase, deoxyuridine triphosphate nucleotidohydrolase; ECM, extracellular matrix; ESCC, oesophageal squamous cell carcinoma; FOXP3, forkhead box P3; FUdR, ﬂoxuridine; GART, glycinamide ribonucleotide transformylase; GDP, guanine diphosphate; GEC, gastroesophageal cancer; Gln, glutamine; GMP, guanine monophosphate; HGPRT, hypoxanthine-guanine phosphoribosyltransferase; HIF-1, hypoxia-inducible factor-1; ICB, immune checkpoint blockade; ICD, immunogenic cell death; ICG, immune checkpoint gene; ICI, immune checkpoint inhibitor; IDO, indoleamine 2,3-dioxygenase; IFN, interferon; IL, interleukin; IME, immune microenvironment; IMP, inosine monophosphate; IMPDH, inosine monophosphate dehydrogenase; IPS, immunophenoscore; LDH, lactate dehydrogenase; LLC, Lewis lung carcinoma; MCT, monocarboxylate transporters; MDSC, myeloid-derived suppressor cell; Mena, mammalian enabled; MHC, major histocompatibility complex; MMP, matrix metallopeptidase; MSI, microsatellite instable; MSS, microsatellite stable; mtDNA, mitochondrial deoxyribonucleic acid; NDPK, nucleotide diphosphate kinase; NF-jB, nuclear factor kappa-light-chain-enhancer of activated B cells; NK, natural killer; NM, nucleotide metabolism; NSCLC, non-small cell lung cancer; NTP, nucleoside triphosphate; PALA, N-phosphonoac","cbCaigKyN7F8T243","https://ap.wps.com/l/cbCaigKyN7F8T243","pdf",2504151,18,"English","# Introduction\n## Nucleotide metabolism and cancer progression\n## NM-driven shaping of the tumour microenvironment\n## Immune suppression and immune evasion\n## Therapeutic strategies targeting nucleotide metabolism\n## Combination with immunotherapies","[{\"question\":\"Why is nucleotide metabolism important for cancer cell growth?\",\"answer\":\"Nucleotide metabolism is required for DNA and RNA synthesis. Cancer cells upregulate nucleotide pathways to meet the demands of rapid proliferation.\"},{\"question\":\"How does altered nucleotide metabolism affect the tumour microenvironment and immune cells?\",\"answer\":\"NM rewiring shapes the tumour microenvironment and can suppress immune response by altering the nucleotide milieu. This impacts immune cell function and viability, supporting immune evasion.\"},{\"question\":\"What therapeutic strategies targeting nucleotide metabolism are discussed?\",\"answer\":\"The review covers strategies such as inhibitors of nucleotide synthesis and drugs targeting salvage pathways. It also emphasizes combining NM-targeted therapies with immunotherapies.\"}]","Harnessing nucleotide metabolism and immunity in cancer: a tumour microenvironment perspective - state-of-the-art review | PDF",1790053408,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dc0d77915132cec7ac2fb9430771e14.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d541a172dee7b64ee78fbad5cd37a51.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce570a94e5d109f3f4a19c9afb54d0c9.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50316463e14e42e00a279836ab93d8cf.webp",980,1287]